Definium Therapeutics DFTX
NASDAQ DFTX
$38.41 +2.24 (+6.19%)
At close: Sep 28, 2026 · 4:00 PM EDT

Definium Therapeutics (DFTX) Operating Expenses (2021 - 2026)

Updated

Definium Therapeutics (DFTX) reported Operating Expenses of $75.08 million for Q2 2026, up 83.5% from $40.9 million a year earlier and up 26.8% from the prior quarter.

Analysis

Definium Therapeutics (DFTX) Operating Expenses (2021 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Definium Therapeutics' Operating Expenses came in at $227.54 million, up 74.6% year-over-year; for FY2025, it was $166.31 million, up 60.0% from FY2024.

  • Operating Expenses has increased for three consecutive years, with a five-year compound annual growth rate of 38.2% (FY2020 to FY2025).
  • By year, Operating Expenses came in at $103.92 million in FY2024 (+10.7%), $93.87 million in FY2023 (+41.5%), $66.33 million in FY2022 (-29.3%) and $93.85 million in FY2021 (+184.1%).
  • The Q2 2026 figure ranks as the highest quarterly Operating Expenses in data going back to Q1 2021.
  • Year over year, Operating Expenses has now increased in each of the last eight quarters, with growth averaging 58.9% over the last eight quarters.
  • The high point for year-over-year Operating Expenses in five years was Q3 2025 (growth of 84.2%); the low point was Q2 2022 (a decline of 62.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $59.22 million (Q1 2026), $47.58 million (Q4 2025) and $45.67 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 10.12 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 10.56 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -9.70 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 2.09 Bn
10 Definium Therapeutics 4.00 Bn 4.00 Bn - 75.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 75.08 Mn
Mar 31, 2026 59.22 Mn
Dec 31, 2025 47.58 Mn
Sep 30, 2025 45.67 Mn
Jun 30, 2025 40.90 Mn
Mar 31, 2025 32.16 Mn
Dec 31, 2024 32.46 Mn
Sep 30, 2024 24.79 Mn
Jun 30, 2024 24.46 Mn
Mar 31, 2024 22.20 Mn
Dec 31, 2023 22.21 Mn
Sep 30, 2023 21.62 Mn
Jun 30, 2023 29.18 Mn
Mar 31, 2023 20.86 Mn
Dec 31, 2022 13.90 Mn
Sep 30, 2022 16.98 Mn
Jun 30, 2022 16.94 Mn
Mar 31, 2022 18.51 Mn
Dec 31, 2021 17.56 Mn
Sep 30, 2021 17.23 Mn
API Access

Definium Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=DFTX&period=max&api_key=YOUR_API_KEY